|
|
|
|
|
Sponsors and Collaborators: |
The Alfred National Health and Medical Research Council, Australia |
Information provided by: | The Alfred |
ClinicalTrials.gov Identifier: | NCT00168233 |
To investigate the effect of treatment of HIV infection with highly active antiretroviral therapy on individual steps of reverse cholesterol transport, endothelial function and intima-media thickness in HIV patients.
Condition |
HIV Infections |
MedlinePlus related topics: | AIDS AIDS Medicines Cholesterol |
ChemIDplus related topics: | Cholest-5-en-3-ol (3beta)- |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Impact of HIV Infection and Treatment With Highly Active Antiretroviral Therapy on Reverse Cholesterol Transport |
Estimated Enrollment: | 75 |
Study Start Date: | June 2005 |
Estimated Study Completion Date: | June 2009 |
Groups/Cohorts |
1
No antiretroviral therapy for 12 months
|
2
Initiating ARV therapy with an NNRTI based regimen
|
3
Initiating ARV therapy with a PI based regimen
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
HIV infected patients naive to ARV therapy
Inclusion Criteria:
Exclusion criteria
Contact: Jennifer Hoy, A/Prof | 0061 3 9276 6900 | Jennifer.Hoy@med.monash.edu.au |
Australia, Victoria | |||||
Alfred Hospital and Baker Heart Research Institute | Recruiting | ||||
Melbourne, Victoria, Australia, 3004 | |||||
Contact: Jennifer Hoy, A/Prof 0061 3 9276 6900 Jennifer.Hoy@med.monash.edu.au |
The Alfred |
National Health and Medical Research Council, Australia |
Study Director: | Dmitri Sviridov, Dr | Baker Heart Research Institute, Commercial Road, Melbourne |
Principal Investigator: | Jennifer Hoy, A/Prof | Alfred Hospital, Melbourne, Vic 3004 |
Responsible Party: | The Alfred ( Prof Jennifer Hoy ) |
Study ID Numbers: | 54/05 |
First Received: | September 9, 2005 |
Last Updated: | May 19, 2008 |
ClinicalTrials.gov Identifier: | NCT00168233 |
Health Authority: | Australia: National Health and Medical Research Council |
|
|
|
|
|